Injectable iohexol syringes recalled for mislabeled iodine strength
BayCare Integrated Service Center is recalling 250 iohexol injection syringes mislabeled as 300 mg iodine/mL but actually containing 350 mg iodine/mL. The labeling error could result in dosing mistakes.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: FDA Class I classification for this pharmaceutical recall establishes a minimum severity score of 4. The dosing discrepancy—350 mg iodine per mL mislabeled as 300 mg—presents a significant risk of medication administration errors, even though no illnesses or injuries have been reported.
Plain-English summary
BayCare Integrated Service Center, LLC (dba BayCare Central Pharmacy) is recalling 250 syringes of iohexol injection, a contrast medium used in medical imaging. The syringes were labeled as containing 300 mg iodine per mL but actually contain 350 mg iodine per mL. The affected product is Lot IOHE2.420221128 with an expiration date of 12/7/2022.
The labeling discrepancy poses a risk of dosing errors if healthcare providers rely on the incorrect label when calculating and administering the contrast media. Patients could receive unintended higher iodine doses than prescribed or ordered by their physician.
The recalled syringes were distributed to BayCare Health System hospitals in Florida. Healthcare facilities should immediately discontinue use of affected syringes and not administer any product from the identified lot number.
Patients who received doses from affected syringes should contact their healthcare provider for medical guidance and advice regarding any necessary follow-up care.
The recalled product
- Product
- Iohexol (300 mg Iodine/mL), 2.4 g Iodine/8 ml, Total Volume 8 ml in 10 ml syringe, 5-count syringes packaged in a bag labeled as Omnipaque (iohexol) 300 mg I/mL, 2.4g Iodine/8 mL in a 10 mL syringe, Compounded with GE Healthcare product, Each mL contains (647 mg) of iohexol as 30
- Manufacturer
- BayCare Integrated Service Center, LLC /dba BayCare Central Pharmacy
- Hazard
- mis-labeling
- dose-discrepancy
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot: IOHE2.420221128
- Exp. 12/7/2022
Distribution
Distributed in 1 state:
- FL
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-06-17
- ModerateVitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid
FDA (Drugs) · 2026-05-27
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27